Overall, these findings support the possible biological implication of our results showing increased Ki-67 and granzyme B expression by tumor infiltrating CD4+ and CD8+ T cells in mice treated with a combination of AHCC® and DICB therapy. This evidence concerns the gene CD4 and neoplasm.